{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15806970", "DateCompleted": {"Year": "2005", "Month": "11", "Day": "21"}, "DateRevised": {"Year": "2008", "Month": "02", "Day": "06"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "1001-5302", "JournalIssue": {"Volume": "30", "Issue": "5", "PubDate": {"Year": "2005", "Month": "Mar"}}, "Title": "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", "ISOAbbreviation": "Zhongguo Zhong Yao Za Zhi"}, "ArticleTitle": "[Suppressive effects of GTW treatment on mesangial lesions in experimental irreversible glomerulosclerosis].", "Pagination": {"StartPage": "361", "EndPage": "365", "MedlinePgn": "361-5"}, "Abstract": {"AbstractText": ["To examine suppressive effects of multi-glycoside of Tripterygium wilfordii Hook. f. (GTW)on mesangial injury induced by two-injecti on of anti-Thy1. 1 monoclonal antibody(mAb) 1-22-3 in vitro.", "We established the irreversible model of glomerulosclerosis with anti-Thy1. 1 mAb 1-22-3. After 42 days of oral treatment with GTW (50 mg x kg(-1) BW)and vehicle (distilled water), to observe effects of GTW on proteinuria, renal function, mesangial morphological change, and mRNA expressions of collagen type I and TGF-beta by light microscope (LM), immunofluorescence (IF), and Reverse Transcription Polymerase Chain Reaction (RT-PCR).", "GTW ameliorated proteinuria (from day24 to day 42) and mesangial proliferation [total cell number, GTW group 65.67+/-3.43 vs. control group 87.02+/-2.41, P < 0.05; matrix expansion, GTW group 1.20+/-0.06 vs. control group 2.77+/-0.23, P < 0.05; alpha-smooth muscle actin(alpha-SMA) expression, GTW group 1.75+/-0.33 vs. control group 2.62+/-0.15, P < 0.05; collagen type I expression, GTW group 1.68+/-0.31 vs. control group 2.06+/-0.24, P < 0.05], moreover, significantly reduced the glomerular expression of mRNA for collagen type 1(53.5% to the control group, P < 0.05)and TGF-beta(14.7% to the control group, P < 0.05)on day 42day.", "GTW can not only decrease proteinuria, but also ameliorate mesangial alterations probably by the reduction of cytokines. GTW may be a promising agent for the prevention of progressive and irreversible glomerulosclerosis."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, Jiangsu, China. wyg68918@sina.com"}], "Identifier": [], "LastName": "Wan", "ForeName": "Yi-gang", "Initials": "YG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sun", "ForeName": "Wei", "Initials": "W"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shmizu", "ForeName": "Fujio", "Initials": "F"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gu", "ForeName": "Liu-bao", "Initials": "LB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Suziki", "ForeName": "Koichi", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Karasawa", "ForeName": "Tamaki", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kawachi", "ForeName": "Hiroshi", "Initials": "H"}], "PublicationTypeList": ["English Abstract", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhongguo Zhong Yao Za Zhi", "NlmUniqueID": "8913656", "ISSNLinking": "1001-5302"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Collagen Type I"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycosides"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta"}, {"RegistryNumber": "11003-00-2", "NameOfSubstance": "Actinin"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Actinin"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["biosynthesis", "genetics"], "DescriptorName": "Collagen Type I"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Glomerular Mesangium"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Glomerulonephritis, Membranoproliferative"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Glycosides"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Proteinuria"}, {"QualifierName": ["biosynthesis", "genetics"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["biosynthesis", "genetics"], "DescriptorName": "Transforming Growth Factor beta"}, {"QualifierName": ["chemistry"], "DescriptorName": "Tripterygium"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "4", "Day": "6", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "12", "Day": "13", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "4", "Day": "6", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15806970"]}}], "PubmedBookArticle": []}